SiVEC Biotechnologies
PrivateLast Round
Seed
Oct 9, 2025
Total Funding Raised
$1.81M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
SiVEC Biotechnologies is a biotechnology company that develops a live biotherapeutic delivery platform called BactPac for the targeted delivery of nucleic acid and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SiVEC Biotechnologies Comparables
Compare SiVEC Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GenCirq, Inc. | 82% | |
| Neobe Therapeutics | 80% | |
| NanoSyrinx | 78% |
SiVEC Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 9, 2025 | ||||
| Grant | Nov 1, 2024 | ||||
| Grant | May 18, 2023 | ||||
| Grant | Sep 1, 2022 | ||||
| Grant | May 21, 2020 | ||||
Grant | Sep 1, 2019 |
SiVEC Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| Silicon Valley Bank | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 180% MoM.
- Jun 19, 2026
Monthly visitors increased 33% MoM, reaching 501.
SiVEC Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SiVEC Biotechnologies's valuation, stock price, and market status.
Is SiVEC Biotechnologies a public or private company?
SiVEC Biotechnologies is a private company.
What is the current stock price of SiVEC Biotechnologies?
SiVEC Biotechnologies is a private company with no public stock price. No recent secondary market data is available.
How much is SiVEC Biotechnologies worth (valuation)?
Valuation information for SiVEC Biotechnologies is not publicly available.
Can I buy SiVEC Biotechnologies stock?
SiVEC Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SiVEC Biotechnologies's last funding round?
SiVEC Biotechnologies's most recent funding round was Seed on October 9, 2025.
Who are the main investors in SiVEC Biotechnologies?
Key investors in SiVEC Biotechnologies include National Institute of Allergy and Infectious Diseases.
Will SiVEC Biotechnologies IPO soon?
No public IPO plans have been announced for SiVEC Biotechnologies.
How can I track SiVEC Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SiVEC Biotechnologies's secondary market activity and sign up for updates.